Thoracic VCAR

Chronic Obstructive Pulmonary Disease (COPD), asthma, pneumonias and viral respiratory infection such as COVID-19, tuberculosis and lung cancer are among the most common causes of severe illness and death worldwide.¹

Respiratory diseases account for more than 10% of all disability adjusted life-years (DALYs). Altogether, 1 billion+ people suffer from either acute or chronic respiratory conditions.¹

CT is widely used to aid in the assessment of COPD, lung nodules and lung infections such as pneumonias or other viral respiratory infections. Chest and Lung CT procedures represent about 18% of overall CT procedures.²

Discreminating volume of healthy lung versus disease presence requires reliable and robust lung segmentation for consistent volume measurements.

Characterize areas of low and high attenuation within the lungs and identify disease patterns such as Ground Glass Opacity or vascular dilatation.

Evaluate the physiological impact of the disease to the lung tissue.

The clinical environment has changed. Your referring physicians need quick, detailed understanding of pathologies to deliver effective patient therapy. They expect faster, more advanced views of abnormal conditions across the entire range of care areas. With AW, you're able to deliver what they need.